X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (504) 504
Publication (34) 34
Conference Proceeding (24) 24
Patent (15) 15
Book Chapter (4) 4
Data Set (3) 3
Book Review (2) 2
Dissertation (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (190) 190
female (139) 139
index medicus (136) 136
endocrinology & metabolism (131) 131
male (125) 125
middle aged (122) 122
adult (119) 119
aged (99) 99
oncology (61) 61
cancer (56) 56
adolescent (51) 51
carcinoma (51) 51
retrospective studies (49) 49
thyroid neoplasms - pathology (48) 48
internal medicine (42) 42
treatment outcome (41) 41
aged, 80 and over (38) 38
prognosis (37) 37
thyroid cancer (36) 36
young adult (36) 36
child (32) 32
thyroid neoplasms - surgery (32) 32
abridged index medicus (30) 30
follow-up studies (30) 30
management (28) 28
metastases (28) 28
positron-emission-tomography (28) 28
tumors (27) 27
follow-up (25) 25
metastasis (25) 25
survival (25) 25
medicine & public health (24) 24
thyroidectomy (24) 24
radiology, nuclear medicine & medical imaging (23) 23
surgery (22) 22
fluorodeoxyglucose f18 (21) 21
iodine radioisotopes - therapeutic use (21) 21
neoplasm staging (20) 20
positron-emission tomography (19) 19
thyroid neoplasms - diagnostic imaging (19) 19
lymphatic metastasis (18) 18
radiopharmaceuticals (18) 18
tomography, x-ray computed (18) 18
antineoplastic agents - therapeutic use (17) 17
chemotherapy (17) 17
diagnosis (17) 17
papillary (17) 17
prospective studies (17) 17
radioactive iodine (17) 17
risk factors (17) 17
thyroid neoplasms - drug therapy (17) 17
thyroid neoplasms - radiotherapy (17) 17
infant (16) 16
pet (16) 16
thyroid neoplasms - therapy (16) 16
survival analysis (15) 15
therapy (15) 15
bone metastases (14) 14
care and treatment (14) 14
disease-free survival (14) 14
neoplasm metastasis (14) 14
prognostic-factors (14) 14
accessories, closures, or fittings therefor (13) 13
adrenocortical carcinoma - drug therapy (13) 13
cancer patients (13) 13
carcinoma - pathology (13) 13
containers for storage or transport of articles or materials,e.g. bags, barrels, bottles, boxes, cans, cartons, crates,drums, jars, tanks, hoppers, forwarding containers (13) 13
conveying (13) 13
expression (13) 13
handling thin or filamentary material (13) 13
immunization (13) 13
medicine, general & internal (13) 13
packages (13) 13
packaging elements (13) 13
packing (13) 13
performing operations (13) 13
pet imaging (13) 13
storing (13) 13
survival rate (13) 13
transporting (13) 13
child, preschool (12) 12
phase-ii trial (12) 12
recurrence (12) 12
sensitivity and specificity (12) 12
thyroid (12) 12
vaccines (12) 12
ablation (11) 11
carcinoma, papillary (11) 11
children (11) 11
efficacy (11) 11
hormone withdrawal (11) 11
malaria (11) 11
neck dissection (11) 11
patients (11) 11
thyroglobulin - blood (11) 11
ultrasonography (11) 11
animals (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
astrophysics (10) 10
combined modality therapy (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 897 - 905
Summary Background No effective standard treatment exists for patients with radioiodine-refractory, advanced differentiated thyroid carcinoma. We aimed to... 
Hematology, Oncology and Palliative Medicine | CRITERIA | MALIGNANT-TUMORS | SOLID TUMORS | ONCOLOGY | PAPILLARY | SORAFENIB | INHIBITOR | CARCINOMA | ZD6474 | Carcinoma | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Antineoplastic Agents - therapeutic use | Diarrhea - chemically induced | Young Adult | Lung Neoplasms - secondary | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Adult | Female | ErbB Receptors - antagonists & inhibitors | Thyroid Neoplasms - mortality | Double-Blind Method | Kaplan-Meier Estimate | Electrocardiography - drug effects | Heart Conduction System - drug effects | Lymphatic Metastasis | Thyroid Cancer, Papillary | Disease-Free Survival | Adenocarcinoma, Follicular | Thyroid Neoplasms - drug therapy | Carcinoma, Papillary | Piperidines - therapeutic use | Quinazolines - therapeutic use | Piperidines - adverse effects | Adolescent | Quinazolines - adverse effects | Skin Neoplasms - secondary | Survival Analysis | Thyroid Neoplasms - secondary | Aged | Thyroid Neoplasms - pathology | Tyrosine | Care and treatment | Thyroid cancer | Clinical trials | Product development | Metastasis | Vascular endothelial growth factor | Cancer | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Lancet Diabetes & Endocrinology, The, ISSN 2213-8587, 2016, Volume 4, Issue 11, pp. 933 - 942
Summary The incidence of differentiated thyroid cancer is increasing greatly in high-income countries. Roughly 50% of this increase is attributable to the... 
Endocrinology & Metabolism | Other | BRAF V600E | BRAFV600E MUTATION | INCREASING INCIDENCE | LYMPH-NODE METASTASIS | PROGNOSTIC-FACTORS | RISK STRATIFICATION | CANCER INCIDENCE | ENDOCRINOLOGY & METABOLISM | FOLLOW-UP | CARCINOMA | RADIOFREQUENCY ABLATION | Watchful Waiting | Thyroid Neoplasms | Carcinoma, Papillary | Medical Overuse | Humans
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 18, pp. 1663 - 1673
This trial compared two thyrotropin-stimulation methods and two 131I doses for postoperative ablation in patients with low-risk thyroid cancer. Rates of... 
RECOMBINANT HUMAN THYROTROPIN | CARCINOMA PATIENTS | MEDICINE, GENERAL & INTERNAL | STIMULATED THYROGLOBULIN | REMNANT ABLATION | HORMONE WITHDRAWAL | FOLLOW-UP | PREDICTIVE-VALUE | SERUM THYROGLOBULIN LEVELS | QUALITY-OF-LIFE | RADIOACTIVE IODINE | Adenocarcinoma, Follicular - radiotherapy | Follow-Up Studies | Neck - diagnostic imaging | Humans | Middle Aged | Ablation Techniques | Male | Iodine Radioisotopes - adverse effects | Iodine Radioisotopes - therapeutic use | Thyrotropin - adverse effects | Thyroid Hormones - blood | Adenocarcinoma, Follicular - drug therapy | Ultrasonography | Adult | Female | Thyrotropin - therapeutic use | Thyroid Hormones - therapeutic use | Adenocarcinoma, Follicular - surgery | Thyroid Neoplasms - surgery | Carcinoma, Papillary - drug therapy | Treatment Outcome | Combined Modality Therapy | Thyroid Neoplasms - radiotherapy | Carcinoma, Papillary - surgery | Thyroidectomy | Hypothyroidism - etiology | Carcinoma, Papillary - radiotherapy | Thyroid Neoplasms - drug therapy | Quality of Life | Drugs | Dose-response relationship (Biochemistry) | Treatment outcome | Evaluation | Usage | Care and treatment | Patient outcomes | Radiofrequency ablation | Product/Service Evaluations | Thyroid cancer | Thyrotropin | Dosage and administration | Drug therapy, Combination | Drug therapy | Isotopes | Iodine | Risk groups | Event-related potentials | Thyroid gland | Contamination | Thyroid carcinoma | Metastases | Thyroid-stimulating hormone | Thyroglobulin | Neck | Cancer | Thyroid
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 2013, Volume 106, pp. S20 - S20
Journal Article
Annals of Endocrinology (Annales D'Endocrinologie, English Edition), ISSN 0003-4266, 2016, Volume 77, Issue 4, pp. 247 - 247
La prise en charge des carcinomes thyroïdiens différenciés (CTD) métastatiques et réfractaires à l’iode radioactif, tout comme celle des carcinomes médullaires... 
Internal Medicine | Endocrinology & Metabolism
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 23, pp. 2189 - 2197
Journal Article
Endocrine-Related Cancer, ISSN 1351-0088, 03/2019, Volume 26, Issue 3, pp. R131 - R143
Journal Article